» Articles » PMID: 35978391

Access to Unpublished Protocols and Statistical Analysis Plans of Randomised Trials

Overview
Journal Trials
Publisher Biomed Central
Date 2022 Aug 17
PMID 35978391
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Access to protocols and statistical analysis plans (SAPs) increases the transparency of randomised trial by allowing readers to identify and interpret unplanned changes to study methods, however they are often not made publicly available. We sought to determine how often study investigators would share unavailable documents upon request.

Methods: We used trials from two previously identified cohorts (cohort 1: 101 trials published in high impact factor journals between January and April of 2018; cohort 2: 100 trials published in June 2018 in journals indexed in PubMed) to determine whether study investigators would share unavailable protocols/SAPs upon request. We emailed corresponding authors of trials with no publicly available protocol or SAP up to four times.

Results: Overall, 96 of 201 trials (48%) across the two cohorts had no publicly available protocol or SAP (11/101 high-impact cohort, 85/100 PubMed cohort). In total, 8/96 authors (8%) shared some trial documentation (protocol only [n = 5]; protocol and SAP [n = 1]; excerpt from protocol [n = 1]; research ethics application form [n = 1]). We received protocols for 6/96 trials (6%), and a SAP for 1/96 trial (1%). Seventy-three authors (76%) did not respond, 7 authors responded (7%) but declined to share a protocol or SAP, and eight email addresses were invalid (8%). A total of 329 emails were sent (an average of 41 emails for every trial which sent documentation). After emailing authors, the total number of trials with an available protocol increased by only 3%, from 52% in to 55%.

Conclusions: Most study investigators did not share their unpublished protocols or SAPs upon direct request. Alternative strategies are needed to increase transparency of randomised trials and ensure access to protocols and SAPs.

Citing Articles

Guidelines for the content of statistical analysis plans in clinical trials: protocol for an extension to cluster randomized trials.

Hemming K, Thompson J, Hooper R, Ukoumunne O, Li F, Caille A Trials. 2025; 26(1):72.

PMID: 40011934 PMC: 11866560. DOI: 10.1186/s13063-025-08756-3.


How can we make sound replication decisions?.

Davis-Stober C, Sarafoglou A, Aczel B, Chandramouli S, Errington T, Field S Proc Natl Acad Sci U S A. 2025; 122(5):e2401236121.

PMID: 39869811 PMC: 11804638. DOI: 10.1073/pnas.2401236121.


A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies.

Modi N, Kichenadasse G, Hoffmann T, Haseloff M, Logan J, Veroniki A BMC Med. 2023; 21(1):400.

PMID: 37872545 PMC: 10594907. DOI: 10.1186/s12916-023-03113-0.

References
1.
Naudet F, Sakarovitch C, Janiaud P, Cristea I, Fanelli D, Moher D . Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published in and . BMJ. 2018; 360:k400. PMC: 5809812. DOI: 10.1136/bmj.k400. View

2.
Greenberg L, Jairath V, Pearse R, Kahan B . Pre-specification of statistical analysis approaches in published clinical trial protocols was inadequate. J Clin Epidemiol. 2018; 101:53-60. DOI: 10.1016/j.jclinepi.2018.05.023. View

3.
Schulz K, Altman D, Moher D . CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010; 340:c332. PMC: 2844940. DOI: 10.1136/bmj.c332. View

4.
Kahan B, Ahmad T, Forbes G, Cro S . Public availability and adherence to prespecified statistical analysis approaches was low in published randomized trials. J Clin Epidemiol. 2020; 128:29-34. DOI: 10.1016/j.jclinepi.2020.07.015. View

5.
Babu C, Mell L, Lee N, Zakeri K . Public access to protocols of contemporary cancer randomized clinical trials. Trials. 2021; 22(1):418. PMC: 8237482. DOI: 10.1186/s13063-021-05382-7. View